# Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients

> **NCT05084872** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Hospital, Toulouse** · enrollment: 30 (estimated)

## Conditions studied

- Mastocytosis

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT05084872
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10
- **Primary completion:** 2024-01
- **Final completion:** 2024-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084872, "Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05084872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*